Non-small cell lung cancer treatment (r)evolution: ten years of advances and more to come
Luca Toschi(IRCCS Humanitas Research Hospital), Armando Santoro(IRCCS Humanitas Research Hospital)
Cited by 48
Related Papers
Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
|Cancer Cell|2010|1.1k
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|724